HUP9903685A2 - Olanzapin alkalmazása túlzott agresszivitás kezelésére szolgáló gyógyszerkészítmények előállítására - Google Patents

Olanzapin alkalmazása túlzott agresszivitás kezelésére szolgáló gyógyszerkészítmények előállítására

Info

Publication number
HUP9903685A2
HUP9903685A2 HU9903685A HUP9903685A HUP9903685A2 HU P9903685 A2 HUP9903685 A2 HU P9903685A2 HU 9903685 A HU9903685 A HU 9903685A HU P9903685 A HUP9903685 A HU P9903685A HU P9903685 A2 HUP9903685 A2 HU P9903685A2
Authority
HU
Hungary
Prior art keywords
olanzapine
preparation
pharmaceutical compositions
treating excessive
compositions treating
Prior art date
Application number
HU9903685A
Other languages
English (en)
Inventor
Charles M. Beasley
Pierre V. Tran
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Publication of HUP9903685A2 publication Critical patent/HUP9903685A2/hu
Publication of HUP9903685A3 publication Critical patent/HUP9903685A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

A találmány eljárást nyújt emlősök extrém agresszivitásánakkezelésére, ami abból áll, hőgy a kezelendő emlős szervezetébeőlanzapinnak vagy gyógyászati szempőntból alkalmazható sójának,szőlvátjának hatásős mennyiségét jűttatják be. ŕ
HU9903685A 1996-03-11 1996-12-04 Use of olanzapine for the preparation of pharmaceutical compositions treating excessive aggression HUP9903685A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1312796P 1996-03-11 1996-03-11
PCT/US1996/019573 WO1997033584A1 (en) 1996-03-11 1996-12-04 Method for treating excessive aggression

Publications (2)

Publication Number Publication Date
HUP9903685A2 true HUP9903685A2 (hu) 2000-03-28
HUP9903685A3 HUP9903685A3 (en) 2001-12-28

Family

ID=21758447

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903685A HUP9903685A3 (en) 1996-03-11 1996-12-04 Use of olanzapine for the preparation of pharmaceutical compositions treating excessive aggression

Country Status (22)

Country Link
EP (1) EP0900085B1 (hu)
JP (1) JP2000506858A (hu)
KR (1) KR19990087716A (hu)
CN (1) CN1124847C (hu)
AT (1) ATE306269T1 (hu)
AU (1) AU719517B2 (hu)
BR (1) BR9612549A (hu)
CA (1) CA2248753C (hu)
CZ (1) CZ296579B6 (hu)
DE (1) DE69635282T2 (hu)
DK (1) DK0900085T3 (hu)
EA (1) EA000741B1 (hu)
ES (1) ES2249789T3 (hu)
HU (1) HUP9903685A3 (hu)
IL (1) IL126157A (hu)
NO (1) NO323579B1 (hu)
NZ (1) NZ325035A (hu)
PL (1) PL186975B1 (hu)
RO (1) RO117347B1 (hu)
TR (1) TR199801799T2 (hu)
UA (1) UA57727C2 (hu)
WO (1) WO1997033584A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2351718A1 (en) 1998-11-23 2000-06-02 Sepracor Inc. Desmethylolanzapine compositions and methods
US6174882B1 (en) 1998-11-23 2001-01-16 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
ATE253364T1 (de) * 1998-11-23 2003-11-15 Sepracor Inc Olanzapin-n-oxide enthaltende pharmaceutische zusammensetzungen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595535A (en) * 1983-06-06 1986-06-17 Ciba-Geigy Corporation Diazacycloalkyl-1,2,4-triazolo[2,3-c][1,3]benzodiazepines useful as neuroleptic and/or antihistaminic agents
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
CZ292565B6 (cs) * 1995-05-30 2003-10-15 Eli Lilly And Company Použití 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepinu k přípravě farmaceutického prostředku pro léčení kognitivní dysfunkce

Also Published As

Publication number Publication date
EA199800822A1 (ru) 1999-02-25
NZ325035A (en) 2001-06-29
JP2000506858A (ja) 2000-06-06
PL186975B1 (pl) 2004-04-30
ATE306269T1 (de) 2005-10-15
CA2248753C (en) 2008-11-18
IL126157A0 (en) 1999-05-09
CZ290598A3 (cs) 1999-09-15
ES2249789T3 (es) 2006-04-01
UA57727C2 (uk) 2003-07-15
EP0900085A1 (en) 1999-03-10
DK0900085T3 (da) 2006-01-30
EA000741B1 (ru) 2000-02-28
NO984198D0 (no) 1998-09-11
EP0900085B1 (en) 2005-10-12
DE69635282T2 (de) 2006-04-20
WO1997033584A1 (en) 1997-09-18
HUP9903685A3 (en) 2001-12-28
CN1213969A (zh) 1999-04-14
NO323579B1 (no) 2007-06-11
AU719517B2 (en) 2000-05-11
PL328949A1 (en) 1999-03-01
RO117347B1 (ro) 2002-02-28
KR19990087716A (ko) 1999-12-27
BR9612549A (pt) 1999-07-20
CN1124847C (zh) 2003-10-22
EP0900085A4 (en) 2000-12-13
NO984198L (no) 1998-11-02
TR199801799T2 (xx) 1999-01-18
CA2248753A1 (en) 1997-09-18
IL126157A (en) 2002-09-12
AU1284697A (en) 1997-10-01
CZ296579B6 (cs) 2006-04-12
DE69635282D1 (de) 2006-02-23

Similar Documents

Publication Publication Date Title
IL267381A (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
EP0831832A4 (en) METHODS FOR CONTROLLING INFECTIOUS DISEASES USING DICATIONIC BIS-BENZIMIDAZOLES
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
ATE247504T1 (de) Vorrichtung zur behandlung des menschlichen körpers durch endermatische elektrotherapie
EP1108426A3 (en) Use of prostaglandin agonists to treat erectile dysfunction or impotence
BR9708027A (pt) Métodos de tratamento ou prevenção de cistite entersticial
HUP9903685A2 (hu) Olanzapin alkalmazása túlzott agresszivitás kezelésére szolgáló gyógyszerkészítmények előállítására
EP1056458A4 (en) METHODS FOR TREATING PAIN, INCLUDING CHRONIC AND WOMAN-SPECIFIC PAIN
HUP9903688A2 (hu) Olanzapin alkalmazása az autizmus kezelésére szolgáló gyógyszerkészítmény előállítására
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
BR9708037A (pt) Método para o tratamento de abuso de substância
AUPP379698A0 (en) Using ngali nut oil to treat/relieve the pain of arthritis and other similar conditions
ATE268170T1 (de) Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
AU5434899A (en) Cancer treatment
EA199800818A1 (ru) Способ лечения бессонницы
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами
UA34333A (uk) Спосіб лікування тяжких форм флюорозу зубів
UA36252A (uk) Спосіб визначення індивідуальності хворого для вибору адекватної гомеопатичної терапії

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees